XT
RIGL icon

XTX Topco’s Rigel Pharmaceuticals RIGL Stock Holding History

XTX Topco’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,467
Closed -$534K – 4292
2025
Q4 		$534K Sell
12,467
-1,415
-10% -$53.3K 0.01% 1530
2025
Q3 		$393K Buy
+13,882
New +$415K 0.02% 1277
2025
Q2 		– Sell
-16,928
Closed -$305K – 3032
2025
Q1 		$305K Buy
16,928
+6,018
+55% +$122K 0.02% 1398
2024
Q4 		$184K Buy
+10,910
New +$209K 0.02% 1586
2024
Q3 		– Sell
-28,515
Closed -$234K – 2518
2024
Q2 		$234K Sell
28,515
-2,942
-9% -$30.8K 0.02% 1123
2024
Q1 		$466K Buy
31,457
+25,889
+465% +$349K 0.06% 531
2023
Q4 		$80.7K Sell
5,568
-10,856
-66% -$111K 0.02% 1153
2023
Q3 		$177K Buy
16,424
+10,778
+191% +$130K 0.03% 1056
2023
Q2 		$72.8K Sell
5,646
-26,033
-82% -$352K 0.01% 1200
2023
Q1 		$418K Buy
31,679
+29,588
+1,415% +$470K 0.09% 407
2022
Q4 		$31.4K Sell
2,091
-42,381
-95% -$389K 0.01% 1064
2022
Q3 		$525K Buy
44,472
+30,253
+213% +$409K 0.13% 223
2022
Q2 		$161K Buy
14,219
+13,199
+1,294% +$265K 0.07% 519
2022
Q1 		$30K Sell
1,020
-3,306
-76% -$89.5K 0.01% 621
2021
Q4 		$115K Buy
+4,326
New +$131K 0.07% 445
2021
Q3 		– Sell
-3,688
Closed -$160K – 1007
2021
Q2 		$160K Buy
+3,688
New +$139K 0.05% 593

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's RIGL Position: Q1 2026 in Review

XTX Topco sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 12,467 shares — an estimated $534K sold.

XTX Topco first reported a position in RIGL in Q2 2021 and held it in 16 quarters. The position peaked at $534K in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • XTX Topco reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 12,467 Rigel Pharmaceuticals shares in Q1 2026, an estimated $534K.
  • XTX Topco first reported a position in Rigel Pharmaceuticals in Q2 2021 and held it in 16 quarters.
  • XTX Topco's Rigel Pharmaceuticals position peaked at $534K in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.